World News – GB – British study tests whether BCG vaccine protects against COVID


LONDON (Reuters) – The widely used BCG tuberculosis vaccine will be tested on primary care workers in Britain for its effectiveness against COVID-19, according to researchers who lead the British arm of ‘a worldwide trial

The Bacillus Calmette-Guérin (BCG) vaccine, used to protect against tuberculosis, induces a broad innate response of the immune system and has been shown to protect against serious infections or diseases with other pathogens respiratory

« BCG has been shown to enhance immunity in a generalized way, which may offer some protection against COVID-19, » said Professor John Campbell, University of Medicine School of Medicine. ‘Exeter

« We are investigating whether the BCG vaccine could help protect those at risk of COVID-19 If so, we could save lives by administering or supplementing this readily available and cost-effective vaccination »

The UK study is part of a trial led by Australia, which was launched in April and which also has weapons in the Netherlands, Spain and Brazil BCG vaccine is also being tested for protection against COVID-19 in South Africa

UK trial is recruiting volunteers ahead of the winter months which officials say could be difficult as the country grapples with a second wave of infections

British Prime Minister Boris Johnson has indicated that restrictions to stem the pandemic could be in place until spring

The UK branch of the trial, which is run from Exeter in the south-west of England, is looking to recruit 1,000 people to work in care homes and community health care nearby

BCG vaccine, Vaccine, Tuberculosis

News from the world – UK – British study tests whether BCG vaccine protects against COVID


Donnez votre avis et abonnez-vous pour plus d’infos

Vidéo du jour: